IRIS
CANTARINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.355
EU - Europa 20.224
AS - Asia 3.190
AF - Africa 122
SA - Sud America 93
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 16
Totale 46.039
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.296
GB - Regno Unito 6.985
IE - Irlanda 2.957
IT - Italia 2.955
CN - Cina 1.869
UA - Ucraina 1.611
RU - Federazione Russa 1.487
SE - Svezia 1.368
DE - Germania 927
FR - Francia 876
SG - Singapore 778
FI - Finlandia 597
VN - Vietnam 164
CI - Costa d'Avorio 92
NL - Olanda 86
TR - Turchia 80
IN - India 74
CZ - Repubblica Ceca 63
BE - Belgio 61
ES - Italia 60
BR - Brasile 57
PL - Polonia 56
JP - Giappone 53
CA - Canada 48
AU - Australia 34
IR - Iran 28
PK - Pakistan 27
HK - Hong Kong 26
CH - Svizzera 21
EU - Europa 16
LT - Lituania 13
BG - Bulgaria 12
PT - Portogallo 11
EC - Ecuador 10
GR - Grecia 10
RO - Romania 10
CL - Cile 9
DK - Danimarca 9
MA - Marocco 9
EG - Egitto 8
KR - Corea 8
ID - Indonesia 7
LV - Lettonia 7
MK - Macedonia 7
BD - Bangladesh 6
MY - Malesia 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
AR - Argentina 5
EE - Estonia 5
HU - Ungheria 5
NZ - Nuova Zelanda 5
PE - Perù 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AT - Austria 4
BO - Bolivia 4
CY - Cipro 4
IQ - Iraq 4
LK - Sri Lanka 4
LU - Lussemburgo 4
MX - Messico 4
PA - Panama 4
TH - Thailandia 4
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
BY - Bielorussia 3
DZ - Algeria 3
IL - Israele 3
KZ - Kazakistan 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
CO - Colombia 2
ET - Etiopia 2
IM - Isola di Man 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KH - Cambogia 2
NO - Norvegia 2
QA - Qatar 2
TM - Turkmenistan 2
TN - Tunisia 2
TW - Taiwan 2
CR - Costa Rica 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MM - Myanmar 1
NG - Nigeria 1
NP - Nepal 1
VE - Venezuela 1
Totale 46.039
Salva come PNG Salva come JPEG
Città #
Southend 6.689
Fairfield 3.336
Dublin 2.914
Ashburn 1.741
Chandler 1.711
Santa Clara 1.619
Woodbridge 1.578
Wilmington 1.348
Jacksonville 1.313
Houston 1.301
Seattle 1.249
Cambridge 1.124
Siena 853
Ann Arbor 840
Menlo Park 655
Singapore 546
Princeton 536
Nanjing 450
Helsinki 344
Beijing 342
New York 257
Boardman 250
San Mateo 232
San Diego 199
Milan 189
Dong Ket 161
Florence 149
Moscow 141
Nanchang 141
Düsseldorf 127
Rome 121
Shenyang 119
Munich 100
Dearborn 99
Abidjan 92
Shanghai 87
London 71
Tianjin 71
Washington 70
Hebei 68
Jiaxing 66
Changsha 61
Brussels 53
Izmir 53
Jinan 52
Venezia 51
Kunming 50
Norwalk 49
Los Angeles 48
Málaga 45
Guangzhou 38
Kraków 38
Frankfurt am Main 37
Fremont 36
Olomouc 36
Redwood City 34
Toronto 34
Zhengzhou 33
San Francisco 30
Bologna 29
Naples 27
Chicago 25
Lancaster 25
Dallas 23
Hangzhou 23
Brno 22
Tappahannock 22
Livorno 21
Taizhou 21
Changchun 20
Falls Church 20
Lanzhou 19
Ningbo 19
Padova 19
Turin 19
Catania 17
Paris 17
Bari 15
Brescia 15
Nuremberg 15
Perugia 15
Cedar Knolls 13
Fort Worth 13
Lappeenranta 13
Saint Petersburg 13
Amsterdam 12
Cecina 12
Hong Kong 12
Hounslow 12
Sofia 12
São Paulo 12
Aachen 11
Bergamo 11
Chianciano Terme 11
Monza 11
Newark 11
Palermo 11
Renton 11
Salerno 11
Uzzano 11
Totale 34.748
Salva come PNG Salva come JPEG
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 548
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 270
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 263
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 251
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 237
Antiangiogenic VEGF isoform in inflammatory myopathies 235
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 220
The 2014 ACR annual meeting: a bird's eye view of autoimmunity in 2015 219
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 217
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 213
Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups 209
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 208
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 206
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 205
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 205
Genetic mechanisms of critical illness in COVID-19 205
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 204
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 204
Antirheumatic agents in covid-19: is IL-6 the right target? 202
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 197
Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review 197
Peripheral biomarkers' panel for severe COVID-19 patients 197
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 196
Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS) 196
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 195
Weekly oral alendronate in mevalonate kinase deficiency 193
Eosinophils in inflammatory muscle disorders: a morphologic and immunohistological study. 192
Macrophage activation syndrome in the course of monogenic autoinflammatory disorders 191
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 191
Colchicine myopathy and neuromyopathy: two cases with different characteristics 190
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 190
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 185
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 184
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria 184
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 183
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 182
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 181
Partial Rescue of Biochemical Parameters After Hematopoietic Stem Cell Transplantation in a Patient with Prolidase Deficiency Due to Two Novel PEPD Mutations 178
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 176
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 176
Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease 174
Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series 174
Working the endless puzzle of hereditary autoinflammatory disorders. 173
Recommendations for the management of autoinflammatory diseases 172
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 171
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 168
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 168
Autoinflammatory disorders and patients with isolated serosal involvement. 165
Untangling the Web of Systemic Autoinflammatory Diseases 165
Kawasaki syndrome and concurrent Coxsackie virus B3 infection 165
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 165
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 165
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 164
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 163
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 163
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 163
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 161
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 159
IL-6 blockade in the management of non-infectious uveitis 158
Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there? 157
Short- and long-term effects of spa therapy in knee osteoarthritis 157
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 157
Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry 156
Systemic-onset juvenile idiopathic arthritis complicated by early onset amyloidosis in a patient carrying a mutation in the MEFV gene 155
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 155
Glucocorticoids in the management of systemic juvenile idiopathic arthritis 155
Therapeutic effect of spa therapy and short wave therapy in knee osteoarthritis: a randomized, single blind, controlled trial 154
Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease 154
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings 153
Immunometabolic biomarkers of inflammation in Behçet's disease: Relationship with epidemiological profile, disease activity and therapeutic regimes 152
The hereditary autoinflammatory disorders uncovered 151
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 151
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 151
null 150
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease 149
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 149
Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases 149
Pathogen-sugar interactions revealed by universal saturation transfer analysis 148
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 148
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature 148
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases 148
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 148
Effect of hyaluronic acid (MW 500-730 kDa) on proteoglycan and nitric oxide production in human osteoarthritic chondrocyte cultures exposed to hydrostatic pressure 148
Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes 146
Tumour necrosis factor receptor-associated periodic syndrome(TRAPS): State of the art and future perspectives 146
Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature 146
The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry 145
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 145
Clinical and biochemical landmarks in systemic autoinflammatory diseases 144
Coexistence of axial spondyloarthritis and thromboangiitis obliterans in a young woman 144
Efficacy of cyclosporine A treatment in relapsing febrile lobular panniculitis associated with small vessel vasculitis 143
Efficacy of alendronate in the treatment of the SAPHO syndrome. 143
Biological treatments in Behçet's disease: beyond anti-TNF therapy 142
Monogenic autoinflammatory syndromes at a dermatological level 142
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders 142
Effects of Spa therapy on serum leptin and adiponectin levels in patients with knee osteoarthritis 141
Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined 141
Possible chondroprotective effect of canakinumab: an in vitro study on human osteoarthritic chondrocytes 141
The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study 141
Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism 140
Totale 17.706
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.736
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.901 0 0 0 0 0 779 697 1.022 830 776 283 514
2020/20216.819 411 746 218 681 428 992 276 985 409 587 454 632
2021/20225.082 494 567 335 334 286 183 227 204 365 627 508 952
2022/20236.263 409 420 735 889 618 1.264 238 503 653 135 245 154
2023/20245.282 237 162 483 278 230 1.337 1.538 206 43 161 163 444
2024/20255.975 585 708 1.536 794 1.629 723 0 0 0 0 0 0
Totale 47.536